In the BioHarmony Drug Report Database

"Preview" Icon

Clarithromycin

Biaxin, Biaxin Xl (clarithromycin) is a small molecule pharmaceutical. Clarithromycin was first approved as Biaxin on 1991-10-31. It is used to treat bacterial infections, bronchitis, chlamydia infections, duodenal ulcer, and haemophilus infections amongst others in the USA. The pharmaceutical is active against androgen receptor.

 

Trade Name

 

Biaxin, Biaxin Xl
 

Common Name

 

clarithromycin
 

ChEMBL ID

 

CHEMBL1741
 

Indication

 

bacterial infections, bronchitis, chlamydia infections, duodenal ulcer, haemophilus infections, helicobacter infections, infectious skin diseases, mycoplasma pneumonia, nontuberculous mycobacterium infections, otitis media, protozoan infections, sinusitis, staphylococcal infections, streptococcal infections, tonsillitis
 

Drug Class

 

Antibiotics (Streptomyces strains)

Image (chem structure or protein)

Clarithromycin structure rendering